401 related articles for article (PubMed ID: 26422658)
1. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
[TBL] [Abstract][Full Text] [Related]
2. Protease activity in the multi-layered intra-luminal thrombus of abdominal aortic aneurysms.
Folkesson M; Silveira A; Eriksson P; Swedenborg J
Atherosclerosis; 2011 Oct; 218(2):294-9. PubMed ID: 21632052
[TBL] [Abstract][Full Text] [Related]
3. Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity.
Koole D; Zandvoort HJ; Schoneveld A; Vink A; Vos JA; van den Hoogen LL; de Vries JP; Pasterkamp G; Moll FL; van Herwaarden JA
J Vasc Surg; 2013 Jan; 57(1):77-83. PubMed ID: 23127983
[TBL] [Abstract][Full Text] [Related]
4. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
[TBL] [Abstract][Full Text] [Related]
5. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
[TBL] [Abstract][Full Text] [Related]
6. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
7. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
[TBL] [Abstract][Full Text] [Related]
8. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
Speck N; Brandsch C; Schmidt N; Yazdekhasti N; Hirche F; Lucius R; Rimbach G; Stangl GI; Reiss K
J Nutr; 2015 Jun; 145(6):1218-26. PubMed ID: 25926412
[TBL] [Abstract][Full Text] [Related]
9. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
10. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of ADAM10 and ADAM17 in allergic rhinitis.
Chueh HW; Park SK; Hur DY; Bae WY
Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527
[TBL] [Abstract][Full Text] [Related]
12. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
Ebsen H; Lettau M; Kabelitz D; Janssen O
Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
[TBL] [Abstract][Full Text] [Related]
13. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
14. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A
ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846
[TBL] [Abstract][Full Text] [Related]
16. Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space.
Pruessmeyer J; Hess FM; Alert H; Groth E; Pasqualon T; Schwarz N; Nyamoya S; Kollert J; van der Vorst E; Donners M; Martin C; Uhlig S; Saftig P; Dreymueller D; Ludwig A
Blood; 2014 Jun; 123(26):4077-88. PubMed ID: 24833351
[TBL] [Abstract][Full Text] [Related]
17. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
18. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
Ebsen H; Schröder A; Kabelitz D; Janssen O
PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
[TBL] [Abstract][Full Text] [Related]
19. Enhanced matrix-degrading proteolytic activity within the thin thrombus-covered wall of human abdominal aortic aneurysms.
Wiernicki I; Stachowska E; Safranow K; Cnotliwy M; Rybicka M; Kaczmarczyk M; Gutowski P
Atherosclerosis; 2010 Sep; 212(1):161-5. PubMed ID: 20537648
[TBL] [Abstract][Full Text] [Related]
20. Thrombus versus wall biological activities in experimental aortic aneurysms.
Coutard M; Touat Z; Houard X; Leclercq A; Michel JB
J Vasc Res; 2010; 47(4):355-66. PubMed ID: 20016209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
